MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

Knockdown of ERα results in decrease in Mcl-1 mRNA expression. by Jennifer L. Schacter (589790)

Cdk5 inhibition by olomoucine prevents the fragmentation of the Golgi and decreases Tau secretion. by Nguyen-Vi Mohamed (323606)

Proinflammatory signaling pathways were decreased in Ad26.COV2.S vaccinated compared to sham unvaccinated hamsters. by Malika Aid (7303874)

“…<p><b>(A)</b> Boxplots of SARS-CoV-2 transcripts normalized read counts across all animals, vaccinated hamsters are shown in blue and pink, and sham animals in green. …”

Intrathecal injection of mycolactone triggers a decrease of pro-inflammatory cytokines in spinal cord of Sham rats. by Caroline Isaac (4600654)

AtCaM4 decreases GSNOR activity in response to salt stress. by Shuo Zhou (1320660)

Inhibition of <i>de novo</i> lipogenesis decreases intracellular HCV RNA. by Sowmya Narayanan (2826308)

TEM4 depletion decreases TEM4 mRNA and protein levels but no effect on spindle staining by the TEM4 antibody. by Diogjena Katerina Prifti (12988141)

CAK inhibition decreases gene transcription after UV-induced DNA damage. by Hany H. Arab (364331)

Pretreatment with Y-26732 Decreased Caspase-3 Activity in CSCs Induced by Dox. by Lijuan Kan (834976)

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Fe limitation decreases transcriptional regulation over the diel cycle in the model diatom <i>Thalassiosira pseudonana</i> - Fig 2 by Johanna A. L. Goldman (7372724)

Heatmap of metabolites with at least 1.5-fold change (increase or decrease) from 0h following treatment with or without PMA for 5 and 15 min. by Susama Chokesuwattanaskul (5813888)

Relative fold change (relative to untreated control cells) of the <i>HER-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Relative fold change (relative to untreated control cells) of the <i>PTGS-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a time-dependent manner. by Lan Zhang (90951)

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a dose-dependent manner. by Lan Zhang (90951)

Mean decrease in accuracy (MDA) of top 15 urine metabolites. by Liam E. Broughton-Neiswanger (8447220)

“…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”